---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-289930"
form_type: "8-K"
ticker: null
cik: "0001853436"
company_name: "Mercato Partners Acquisition Corp"
filed_at: "2022-11-21T23:59:59+00:00"
generated_at: "2026-06-21T15:17:39.333817+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Mercato Partners Acquisition Corp receives Nasdaq noncompliance letter over Audit Committee composition

## Summary
- Director Joshua James resigned July 19, 2022, reducing Audit Committee to two independent directors, below Nasdaq's minimum of three.
- Nasdaq confirmed noncompliance on Nov 17, 2022; cure period ends at the earlier of next annual meeting or July 19, 2023.
- Company plans to appoint an additional independent director to the Board and Audit Committee prior to cure deadline.

## SEC filing metadata
- accession: 0001193125-22-289930
- form_type: 8-K
- cik: 0001853436
- company_name: Mercato Partners Acquisition Corp
- filed_at: 2022-11-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853436/000119312522289930/0001193125-22-289930-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853436/000119312522289930/d423884d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-289930
- JSON: https://secwatch.observer/filing/0001193125-22-289930.json
- Plain text: https://secwatch.observer/filing/0001193125-22-289930.txt

## Key facts
- Listing & Compliance Notices
  Mercato Partners Acquisition Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: audit committee
  - Rules: 5605(c)(2)(A), 5605(c)(4)(B)
  source text: November 17, 2022, Nasdaq issued a letter to the Company confirming the Company’s noncompliance with Nasdaq Listing Rule 5605 and informing the Company of the cure periods. The Company intends to appoint an additional independent director to the Board and the Audit Committee prior to the end of the cure periods. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Mercato Partners Acquisition Corporation Date: November 21, 2022 By: /s/ Scott Klossner Na
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853436/000119312522289930/0001193125-22-289930-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.